GS0051: Pharmaceuticals; pharmaceuticals as live biotherapeutics; live biotherapeutics for the treatment of inflammatory and autoimmune diseases; live biotherapeutics for the treatment of cancer; live biotherapeutics for the treatment of gastrointestinal diseases; live biotherapeutics for the treatment of central nervous system diseases; live biotherapeutic bacterial formulations for medical use; preparations of microorganisms for medical use
GS0421: Scientific research and development; pharmaceutical research and development; microbiology research and development into live biotherapeutics
Case File Event Statements
8/12/2021 - 3 years ago
5 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAMType:NWOS